F2 rs387906522: Understanding Congenital Prothrombin Deficiency
The genetic variant rs387906522 is located within the F2 gene, which provides instructions for making the prothrombin protein. This specific variant is classified as pathogenic and is associated with congenital prothrombin deficiency, a rare condition that affects the blood's ability to clot properly.
What each genotype means
Typical prothrombin function
This genotype represents the common, expected sequence for the F2 gene. Individuals with this profile do not carry the specific variant associated with congenital prothrombin deficiency at this location.
This is the most common genotype observed across all global populations.
Carrier of prothrombin variant
This genotype indicates you carry one copy of the variant associated with congenital prothrombin deficiency. Because this condition typically follows an autosomal recessive inheritance pattern, carriers are generally asymptomatic, though you should discuss any personal or family history of bleeding disorders with a healthcare provider.
This genotype is rare in the general population, as congenital prothrombin deficiency is an uncommon inherited disorder.
Potential prothrombin deficiency
This genotype indicates you carry two copies of the variant associated with congenital prothrombin deficiency. This may be linked to reduced levels or activity of the prothrombin protein, which can affect blood clotting; please consult with a hematologist or genetic counselor to discuss clinical implications.
This genotype is extremely rare, consistent with the low prevalence of congenital prothrombin deficiency in the general population.
What is rs387906522?
The variant rs387906522 is a specific change in the DNA sequence of the F2 gene, located on chromosome 11. In genetic databases, this variant is often described as an insertion, specifically an insertion of a thymine (T) nucleotide. Because it occurs within the coding region of the F2 gene, it has the potential to alter the structure or function of the resulting protein. Genetic variants like this are identified by their unique reference SNP ID (rsID), which allows researchers to track and study them across different populations. While many genetic variations are harmless, rs387906522 has been identified in clinical settings as a pathogenic variant, meaning it is linked to a specific health condition. Understanding the location and nature of this variant is the first step in determining how it might influence biological processes in the body.
The Role of the F2 Gene
The F2 gene is responsible for producing a protein called prothrombin, also known as coagulation factor II. Prothrombin is a critical component of the body's blood-clotting cascade, a complex series of chemical reactions that stop bleeding after an injury. When a blood vessel is damaged, prothrombin is converted into thrombin, an enzyme that helps form a stable blood clot. If the F2 gene contains a pathogenic variant, the body may produce insufficient amounts of prothrombin or a dysfunctional version of the protein. This can lead to a condition known as congenital prothrombin deficiency, or hypoprothrombinemia. Individuals with this condition may experience symptoms such as easy bruising, nosebleeds, or prolonged bleeding after surgery or injury. Because the clotting process is essential for maintaining vascular health, the proper function of the F2 gene is vital for normal physiological balance.
Research and Clinical Significance
Clinical evidence, including data from databases like ClinVar, classifies rs387906522 as pathogenic in the context of congenital prothrombin deficiency. This classification is based on observations of individuals who carry the variant and exhibit clinical signs of factor II deficiency. The evidence strength for this association is considered moderate, reflecting that while the link is well-documented in clinical literature, the condition itself is rare. It is important to note that genetic associations are statistical in nature; the presence of a pathogenic variant does not guarantee that an individual will experience severe symptoms, as other genetic and environmental factors can influence the severity of the condition. Researchers continue to study how specific mutations in the F2 gene impact protein stability and clotting efficiency. If you have concerns about your genetic results or bleeding history, it is essential to discuss these findings with a qualified healthcare provider or a genetic counselor.
Managing Genetic Information
If you have received information about the rs387906522 variant, it is important to understand what you can and cannot do with this knowledge. Genetic testing provides data, but it does not replace a clinical diagnosis. You cannot use this information to self-diagnose or determine your risk for bleeding disorders without professional medical guidance. A clinician can interpret these results in the context of your personal and family medical history, physical examinations, and specialized blood tests that measure clotting factor levels. If you are concerned about your risk, consult with a hematologist or a genetic specialist who can provide personalized advice. Avoid making changes to any medications or treatment plans based solely on a genetic report. Always work with your healthcare team to ensure that any medical decisions are based on a comprehensive evaluation of your health status.
How common is this variant?
There is no specific population frequency data recorded for this rare variant in major public databases, suggesting it is not common in the general population.
Frequently asked questions
What is congenital prothrombin deficiency?
Congenital prothrombin deficiency is a rare inherited bleeding disorder caused by low levels or poor function of the prothrombin protein. It can lead to symptoms like easy bruising, nosebleeds, and prolonged bleeding after injuries.
Is rs387906522 the same as the Factor II G20210A mutation?
No, they are different. The G20210A mutation (c.*97G>A) is a well-known variant associated with an increased risk of blood clots, whereas rs387906522 is associated with a deficiency in clotting factors.
Should I be worried if I have this variant?
Finding a pathogenic variant does not mean you will definitely have severe health issues. You should discuss your results with a doctor or genetic counselor to understand what they mean for your specific health profile.
How is prothrombin deficiency diagnosed?
Diagnosis typically involves blood tests that measure the activity and levels of clotting factors in your plasma. A doctor will also review your personal and family history of bleeding.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs387906522?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29